RESMED INC — Director's Dealing 2017

Jun 16, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2017-06-14

Reporting Person: PACE GARY W (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-06-14	ResMed Common Stock	M	1730	$33.70	Acquired	99317	Direct
2017-06-14	ResMed Common Stock	S	1730	$76	Disposed	97587	Direct
2017-06-15	ResMed Common Stock	M	22660	$33.70	Acquired	120247	Direct
2017-06-15	ResMed Common Stock	S	22660	$76	Disposed	97587	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-06-14	ResMed Common Stock Options	$33.70	M	1730	Disposed	2017-11-11	ResMed Common Stock (1730)	Direct
2017-06-15	ResMed Common Stock Options	$33.70	M	22660	Disposed	2017-11-11	ResMed Common Stock (22660)	Direct

Footnotes

F1: The transaction was conducted under a Rule 10b5-1 plan.

F2: Represents date options first became exercisable. Options vest one full year following the grant date.